Stock SPECTRANETICS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Spectranetics Corp

Equities

US84760C1071

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Spectranetics Announces Fundamental Change, Make-Whole Adjustment Event, Share Exchange Event and Supplemental Indenture for 2.625% Convertible Senior Notes due 2034
GL
Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
GL
Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon
GL
Spectranetics Announces Second Quarter Earnings Release Date
GL
Brower Piven Commences an Investigation into the Proposed Sale of The Spectranetics Corporation and Encourages Shareholders to Contact the Firm for Additional Information
BU
Brower Piven Commences an Investigation into the Proposed Sale of The Spectranetics Corporation and Encourages Investors to Contact the Firm for Additional Information
BU
Royal Philips : Philips to buy medical device maker Spectranetics for 1.9 billion euros
RE
Philips to acquire The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac and peripheral vascular disease
GL
Spectranetics Announces Election of New Chairperson of the Board of Directors
GL
Spectranetics Announces $140 Million Debt Refinancing
GL
Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
GL
Spectranetics Announces First Quarter 2017 Conference Call
GL
Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
GL
Spectranetics : Announces Fourth Quarter 2016 Conference Call
PU
Spectranetics : ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations
PU
Spectranetics : Names Scott Hutton as General Manager, Vascular Intervention
PU
Spectranetics Announces Fourth Quarter 2016 Conference Call
GL
ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations
GL
Spectranetics Names Scott Hutton as General Manager, Vascular Intervention
GL
Spectranetics to Present at the 35th Annual J.P. Morgan Healthcare Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Spectranetics Corp